Enanta Pharmaceuticals reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
AbbVie 3.1 0.19 Mar/2026
Amgen 2.78 0.17 Mar/2026
Anika Therapeutics 0 0 Mar/2025
AstraZeneca USD 1.18 0.56 Mar/2026
BioCryst Pharmaceuticals 0 0 Mar/2025
Bristol-Myers Squibb 4.12 3.9 Mar/2026
Enanta Pharmaceuticals 0 0 Mar/2025
Gilead Sciences 2.58 0.25 Dec/2025
GlaxoSmithKline 0.82 3.75 Mar/2026
Heron Therapeutics 0 0 Mar/2025
J&J 2.16 0.34 Mar/2026
Karyopharm Therapeutics 0 0 Mar/2025
Merck 2.76 0.36 Mar/2026
Novartis USD 3.33 0.29 Mar/2026
Pfizer 6.91 0.33 Dec/2025
Roche Holding 2.96 0.8 Dec/2025